Savant Capital LLC raised its stake in shares of Monsanto Company (NYSE:MON) by 0.6% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 3,102 shares of the basic materials company’s stock after buying an additional 20 shares during the period. Savant Capital LLC’s holdings in Monsanto were worth $367,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Swiss National Bank boosted its position in Monsanto by 25.6% in the first quarter. Swiss National Bank now owns 1,676,066 shares of the basic materials company’s stock valued at $189,731,000 after buying an additional 341,400 shares in the last quarter. United Services Automobile Association boosted its position in Monsanto by 5.6% in the first quarter. United Services Automobile Association now owns 265,378 shares of the basic materials company’s stock worth $30,041,000 after buying an additional 14,076 shares in the last quarter. Fisher Asset Management LLC bought a new position in Monsanto during the first quarter worth $213,000. WFG Advisors LP boosted its position in Monsanto by 19.4% in the first quarter. WFG Advisors LP now owns 2,377 shares of the basic materials company’s stock worth $269,000 after buying an additional 387 shares in the last quarter. Finally, Bank of The Ozarks boosted its position in Monsanto by 14.2% in the first quarter. Bank of The Ozarks now owns 9,150 shares of the basic materials company’s stock worth $1,035,000 after buying an additional 1,135 shares in the last quarter. Institutional investors and hedge funds own 74.79% of the company’s stock.

Monsanto Company (MON) opened at 116.59 on Wednesday. The firm has a market capitalization of $51.22 billion, a price-to-earnings ratio of 25.18 and a beta of 1.07. The firm has a 50 day moving average price of $117.23 and a 200-day moving average price of $115.65. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. During the same period in the prior year, the company earned $2.17 earnings per share. The company’s quarterly revenue was up 1.0% on a year-over-year basis. On average, equities analysts forecast that Monsanto Company will post $4.89 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date is Thursday, October 5th. Monsanto’s payout ratio is 46.75%.

ILLEGAL ACTIVITY NOTICE: “Savant Capital LLC Increases Position in Monsanto Company (MON)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/30/savant-capital-llc-increases-position-in-monsanto-company-mon.html.

A number of equities analysts have weighed in on the stock. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. Barclays PLC upped their price objective on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 price objective (up previously from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, July 4th. Finally, Citigroup Inc. reaffirmed a “neutral” rating and issued a $126.00 target price (up previously from $125.00) on shares of Monsanto in a research report on Monday, July 10th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company. Monsanto presently has a consensus rating of “Hold” and a consensus target price of $123.43.

In related news, SVP Janet M. Holloway sold 3,337 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the completion of the sale, the senior vice president now directly owns 44,405 shares in the company, valued at $5,239,790. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold a total of 74,470 shares of company stock valued at $8,791,281 over the last quarter. 0.79% of the stock is owned by corporate insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.